EchoIQ Limited (ECHOiQ), formerly Houston We Have Limited, is an Australia-based health and medical technology company. The Company is engaged in the product development, marketing and commercialization of software products and services. It provides cardiac diagnostics technology. ECHOiQ’s technology uses artificial intelligence (ai) assisted diagnostics to deliver real-world health solutions. Its screening program uses an AI backed system and access to cardiac big data that identifies patients at risk from aortic stenosis and other forms of structural heart disease. The Company’s technology addresses aortic stenosis, heart failure, and mitral and tricuspid regurgitation.